Advertisement

Understanding Social Structural Barriers and Facilitators to Behavioral Change: The Case of Cisgender Women Diagnosed with HIV

Chapter
  • 540 Downloads
Part of the Nebraska Symposium on Motivation book series (NSM, volume 65)

Abstract

In the USA, to receive a diagnosis of human immunodeficiency virus (HIV) is to be expected to embark on a lifelong course of medical, lifestyle, and interpersonal change. To preserve their health, people with HIV are expected to take daily medication, remain in medical care for HIV and get screened and treated for other co-occurring health problems, to develop and/or maintain a healthy lifestyle and to cope with the ongoing stigma and social isolation associated with the diagnosis. In particular, cisgender women who are at the margins of society face social, medical, financial, and structural barriers that render them uniquely vulnerable to contracting HIV, and those same barriers impede diagnosis, beginning care, and staying in care. Most interventions to ensure that PLHIV maintain cART adherence and remain in medical care are biomedically focused and therefore centered on individual-level, behavioral-based interventions. Yet, there are numerous structural barriers that interfere with individual behaviors and compound individual suffering. This chapter serves as an introduction to HIV/AIDS epidemiology, treatment, and policy for people living with HIV/AIDS with a specific focus on cisgender women. In it we utilize a constrained choice approach to systematically examine how decisions made and actions taken at the levels of family, workplace, community, and governmental policy can create barriers to initiating and maintaining cART adherence for PLHIV generally and cWLHIV specifically, and how these barriers can be successfully remedied through local, state, and federal policies.

Keywords

HIV/AIDS Cisgender women with HIV Constrained choice Health disparities Women with HIV 

References

  1. Addo, M. M., & Altfeld, M. (2014). Sex-based differences in HIV type 1 pathogenesis. The Journal of Infectious Diseases, 209(suppl_3), S86–S92.PubMedPubMedCentralCrossRefGoogle Scholar
  2. Adimora, A. A., & Auerbach, J. D. (2010). Structural interventions for HIV prevention in the United States. Journal of Acquired Immune Deficiency Syndromes (1999), 55(02), S132.CrossRefGoogle Scholar
  3. Adimora, A. A., Hughes, J. P., Wang, J., Haley, D. F., Golin, C. E., Magnus, M., … Mannheimer, S. (2014). Characteristics of multiple and concurrent partnerships among women at high risk for HIV infection. Journal of Acquired Immune Deficiency Syndromes (1999), 65(1), 99.CrossRefGoogle Scholar
  4. Adimora, A. A., Ramirez, C., Schoenbach, V. J., & Cohen, M. S. (2014). Policies and politics that promote HIV infection in the Southern United States. AIDS, 28(10), 1393.PubMedPubMedCentralCrossRefGoogle Scholar
  5. Adimora, A. A., Schoenbach, V. J., & Doherty, I. A. (2006). HIV and African Americans in the southern United States: sexual networks and social context. Sexually Transmitted Diseases, 33(7), S39–S45.PubMedCrossRefGoogle Scholar
  6. Agency for Healthcare Research and Quality. (2014a, May). 2013 national healthcare disparities report. Retrieved from https://archive.ahrq.gov/research/findings/nhqrdr/nhdr13/index.html
  7. Agency for Healthcare Research and Quality. (2014b, April). CAHPS: Assessing health care quality from the patient’s perspective. AHRQ Pub. No. 14-P004-EF.Google Scholar
  8. Ahmed, A., Hanssens, C., & Kelly, B. (2009). Protecting HIV-positive women’s human rights: Recommendations for the United States National HIV/AIDS Strategy. Reproductive Health Matters, 17(34), 127–134.PubMedCrossRefGoogle Scholar
  9. Aidala, A. A., Wilson, M. G., Shubert, V., Gogolishvili, D., Globerman, J., Rueda, S., … Rourke, S. B. (2016). Housing status, medical care, and health outcomes among people living with HIV/AIDS: A systematic review. American Journal of Public Health, 106(1), e1–e23.PubMedPubMedCentralCrossRefGoogle Scholar
  10. Alonzo, A. A., & Reynolds, N. R. (1995). Stigma, HIV and AIDS: An exploration and elaboration of a stigma trajectory. Social Science & Medicine, 41(3), 303–315.CrossRefGoogle Scholar
  11. Andersen, R. M., Davidson, P. L., & Baumeister, S. E. (2014). Improving access to care. In G. F. Kominski (Ed.), Changing the US health care system: Key issues in health services policy and management (pp. 33–68). San Francisco, CA: Jossey-Bass.Google Scholar
  12. Anderson, D. K., & Saunders, D. G. (2003). Leaving an abusive partner: An empirical review of predictors, the process of leaving, and psychological well-being. Trauma, Violence & Abuse, 4(2), 163–191.CrossRefGoogle Scholar
  13. Andrykowski, M. A., Cordova, M. J., Studts, J. L., & Miller, T. W. (1998). Posttraumatic stress disorder after treatment for breast cancer: Prevalence of diagnosis and use of the PTSD Checklist—Civilian Version (PCL—C) as a screening instrument. Journal of Consulting and Clinical Psychology, 66(3), 586–590.PubMedCrossRefGoogle Scholar
  14. Antiretroviral Therapy Cohort Collaboration. (2008). Life expectancy of individuals on combination antiretroviral therapy in high-income countries: A collaborative analysis of 14 cohort studies. The Lancet, 372(9635), 293–299.CrossRefGoogle Scholar
  15. Ayanian, J. Z., Weissman, J. S., Schneider, E. C., Ginsburg, J. A., & Zaslavsky, A. M. (2000). Unmet health needs of uninsured adults in the United States. JAMA, 284(16), 2061–2069.PubMedCrossRefGoogle Scholar
  16. Bangsberg, D. R., Ragland, K., Monk, A., & Deeks, S. G. (2010). A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV+ homeless and marginally housed people. AIDS, 24(18), 2835–2840.PubMedPubMedCentralCrossRefGoogle Scholar
  17. Baral, S. D., Poteat, T., Strömdahl, S., Wirtz, A. L., Guadamuz, T. E., & Beyrer, C. (2013). Worldwide burden of HIV in transgender women: A systematic review and meta-analysis. The Lancet Infectious Diseases, 13(3), 214–222.PubMedCrossRefGoogle Scholar
  18. Bedimo, A. L., Pinkerton, S. D., Cohen, D. A., Gray, B., & Farley, T. A. (2002). Condom distribution: A cost–utility analysis. International Journal of STD & AIDS, 13(6), 384–392.CrossRefGoogle Scholar
  19. Berger, M. T. (2010). Workable sisterhood: The political journey of stigmatized women with HIV/AIDS. Princeton, NJ: Princeton University Press.Google Scholar
  20. Bird, C. E., & Lang, M. E. (2014). Gender, health, and constrained choice. In W. C. Cockerham, R. Dingwall, & S. R. Quah (Eds.), The Wiley Blackwell encyclopedia of health, illness, behavior, and society. Hoboken, NJ: John Wiley & Sons.Google Scholar
  21. Bird, C. E., Lang, M. E., & Rieker, P. P. (2012). Changing gendered patterns of morbidity and mortality. In E. Kuhlmann & E. Annandale (Eds.), The Palgrave handbook of gender and healthcare (pp. 145–161). London, England: Palgrave Macmillan.Google Scholar
  22. Bird, C. E., & Rieker, P. P. (2008). Gender and health: The effects of constrained choices and social policies. New York, NY: Cambridge University Press.CrossRefGoogle Scholar
  23. Bottonari, K. A., Safren, S. A., McQuaid, J. R., Hsiao, C. B., & Roberts, J. E. (2010). A longitudinal investigation of the impact of life stress on HIV treatment adherence. Journal of Behavioral Medicine, 33(6), 486–495.PubMedPubMedCentralCrossRefGoogle Scholar
  24. Bowleg, L. (2008). When Black+ lesbian+ woman≠ Black lesbian woman: The methodological challenges of qualitative and quantitative intersectionality research. Sex Roles, 59(5–6), 312–325.CrossRefGoogle Scholar
  25. Bowleg, L. (2012). The problem with the phrase women and minorities: Intersectionality—an important theoretical framework for public health. American Journal of Public Health, 102(7), 1267–1273.PubMedPubMedCentralCrossRefGoogle Scholar
  26. Bradley, H., Hall, H. I., Wolitski, R. J., Van Handel, M. M., Stone, A. E., LaFlam, M., … Valleroy, L. A. (2014). Vital signs: HIV diagnosis, care, and treatment among persons living with HIV—United States, 2011. MMWR. Morbidity and Mortality Weekly Report, 63(47), 1113–1117.PubMedPubMedCentralGoogle Scholar
  27. Brezing, C., Ferrara, M., & Freudenreich, O. (2015). The syndemic illness of HIV and trauma: Implications for a trauma-informed model of care. Psychosomatics, 56(2), 107–118.PubMedCrossRefGoogle Scholar
  28. Brown, J. L., Vanable, P. A., Naughton, J. D., & Carey, M. P. (2015). Identifying HIV-Infected women’s psychosocial stressors: Findings from a qualitative study. Journal of HIV/AIDS & Social Services, 14(2), 188–205.CrossRefGoogle Scholar
  29. Campbell, J. C., Baty, M. L., Ghandour, R. M., Stockman, J. K., Francisco, L., & Wagman, J. (2008). The intersection of intimate partner violence against women and HIV/AIDS: A review. International Journal of Injury Control and Safety Promotion, 15(4), 221–231.PubMedPubMedCentralCrossRefGoogle Scholar
  30. Carr, R. L., & Gramling, L. F. (2004). Stigma: A health barrier for women with HIV/AIDS. Journal of the Association of Nurses in AIDS Care, 15(5), 30–39.PubMedCrossRefGoogle Scholar
  31. Centers for Disease Control and Prevention. (2010). Racial/ethnic disparities among children with diagnoses of perinatal HIV infection-34 states, 2004–2007. MMWR. Morbidity and Mortality Weekly Report, 59(4), 97.Google Scholar
  32. Centers for Disease Control and Prevention. (2016a, November). HIV in the United States by geographic distribution. Retrieved from https://www.cdc.gov/hiv/pdf/statistics/cdc-hiv-geographic-distribution.pdf
  33. Centers for Disease Control and Prevention. (2016b, November). HIV surveillance report, 2015 (Vol. 27). Retrieved from http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html
  34. Centers for Disease Control and Prevention. (2016c, July). Monitoring selected national HIV prevention and care objectives by using HIV surveillance data United States and 6 dependent areas, 2014. Retrieved from https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-supplemental-report-vol-21-4.pdf
  35. Centers for Disease Control and Prevention. (2016d, February). Trends in HIV diagnoses, 2005–2014. Retrieved from https://www.cdc.gov/nchhstp/newsroom/docs/factsheets/hiv-data-trends-fact-sheet-508.pdf
  36. Centers for Disease Control and Prevention. (2017a, June 9). HIV among African-Americans. Retrieved from https://www.cdc.gov/hiv/group/racialethnic/africanamericans/index.html
  37. Centers for Disease Control and Prevention. (2017b, March 9). HIV among Hispanics/Latinos. Retrieved from https://www.cdc.gov/hiv/group/racialethnic/hispaniclatinos/index.html
  38. Centers for Disease Control and Prevention. (2017c, March 10). HIV among pregnant women, infants, and children. Retrieved from https://www.cdc.gov/hiv/group/gender/pregnantwomen/index.html
  39. Centers for Disease Control and Prevention. (2017d, March 10). HIV among women. Retrieved from https://www.cdc.gov/hiv/group/gender/women/index.html
  40. Centers for Disease Control and Prevention. (2017e, March 8). HIV cost-effectiveness | guidance | program resources | HIV/AIDS | CDC. Retrieved July 7, 2017, from https://www.cdc.gov/hiv/programresources/guidance/costeffectiveness/index.html
  41. Centers for Disease Control and Prevention. (2017f, June 8). HIV in the United States: At a glance. Retrieved from https://www.cdc.gov/hiv/statistics/overview/ataglance.html
  42. Centers for Disease Control and Prevention. (2017g, January 13). Leading causes of death in females, 2014 (current listing). Retrieved from https://www.cdc.gov/women/lcod/2014/black/index.htm
  43. Chesney, M. A. (2006). The elusive gold standard: Future perspectives for HIV adherence assessment and intervention. JAIDS Journal of Acquired Immune Deficiency Syndromes, 43, S149–S155.PubMedCrossRefGoogle Scholar
  44. Choudhry, N. K., Lee, J. L., Agnew-Blais, J., Corcoran, C., & Shrank, W. H. (2009). Drug company–sponsored patient assistance programs: A viable safety net? Health Affairs, 28(3), 827–834.PubMedCrossRefGoogle Scholar
  45. Ciambrone, D. (2003). Women’s experiences with HIV/AIDS: Mending fractured selves. Binghamton, NY: Haworth Press.Google Scholar
  46. Claborn, K. R., Meier, E., Miller, M. B., & Leffingwell, T. R. (2015). A systematic review of treatment fatigue among HIV-infected patients prescribed antiretroviral therapy. Psychology, Health & Medicine, 20(3), 255–265.CrossRefGoogle Scholar
  47. Clavel, F., & Hance, A. J. (2004). HIV drug resistance. New England Journal of Medicine, 350(10), 1023–1035.PubMedCrossRefGoogle Scholar
  48. Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., … Godbole, S. V. (2016). Antiretroviral therapy for the prevention of HIV-1 transmission. New England Journal of Medicine, 375(9), 830–839.PubMedCrossRefGoogle Scholar
  49. Colfax, G. N., Buchbinder, S. P., Cornelisse, P. G., Vittinghoff, E., Mayer, K., & Celum, C. (2002). Sexual risk behaviors and implications for secondary HIV transmission during and after HIV seroconversion. AIDS, 16(11), 1529–1535.PubMedCrossRefGoogle Scholar
  50. Crenshaw, K. (1989). Demarginalizing the intersection of race and sex: A black feminist critique of antidiscrimination doctrine, feminist theory and antiracist politics. University of Chicago Legal Forum, 1989(1), 139–167.Google Scholar
  51. Curno, M. J., Rossi, S., Hodges-Mameletzis, I., Johnston, R., Price, M. A., & Heidari, S. (2016). A systematic review of the inclusion (or exclusion) of women in HIV research: From clinical studies of antiretrovirals and vaccines to cure strategies. JAIDS Journal of Acquired Immune Deficiency Syndromes, 71(2), 181–188.PubMedCrossRefGoogle Scholar
  52. Darlington, C. K., & Hutson, S. P. (2017). Understanding HIV-related stigma among women in the Southern United States: A literature review. AIDS and Behavior, 21(1), 12–26.PubMedCrossRefGoogle Scholar
  53. Das, M., Chu, P. L., Santos, G. M., Scheer, S., Vittinghoff, E., McFarland, W., & Colfax, G. N. (2010). Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One, 5(6), 1–9. https://doi.org/10.1371/journal.pone.0011068 CrossRefGoogle Scholar
  54. Deeks, S. G. (2011). HIV infection, inflammation, immunosenescence, and aging. Annual Review of Medicine, 62, 141–155.PubMedPubMedCentralCrossRefGoogle Scholar
  55. Denning, P., & DiNenno, E. (2017, May 17). Communities in crisis: Is there a generalized HIV epidemic in impoverished urban areas of the United States? Retrieved from https://www.cdc.gov/hiv/group/poverty.html
  56. Dieffenbach, C. W., & Fauci, A. S. (2009). Universal voluntary testing and treatment for prevention of HIV transmission. JAMA, 301(22), 2380–2382.PubMedCrossRefGoogle Scholar
  57. District of Columbia Department of Health HIV/AIDS, Hepatitis, STD, and TB Administration. (2016). Annual epidemiology & surveillance report: Surveillance data through December 2015. Retrieved from https://doh.dc.gov/sites/default/files/dc/sites/doh/publication/attachments/2016%20HAHSTA%20Annual%20Epi%20&%20Surv%20Report%20final.pdf
  58. Dodd, P. J., Garnett, G. P., & Hallett, T. B. (2010). Examining the promise of HIV elimination by ‘test and treat’ in hyper-endemic settings. AIDS, 24(5), 729.PubMedPubMedCentralCrossRefGoogle Scholar
  59. Donnelly, C. A., Bartley, L. M., Ghani, A. C., Le Fevre, A. M., Kwong, G. P., Cowling, B. J., … Anderson, R. M. (2005). Gender difference in HIV-1 RNA viral loads. HIV Medicine, 6(3), 170–178.PubMedCrossRefGoogle Scholar
  60. Earnshaw, V. A., Smith, L. R., Chaudoir, S. R., Amico, K. R., & Copenhaver, M. M. (2013). HIV stigma mechanisms and well-being among PLWH: A test of the HIV stigma framework. AIDS and Behavior, 17(5), 1785–1795.PubMedPubMedCentralCrossRefGoogle Scholar
  61. Fleming, D. T., & Wasserheit, J. N. (1999). From epidemiological synergy to public health policy and practice: The contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sexually Transmitted Infections, 75(1), 3–17.PubMedPubMedCentralCrossRefGoogle Scholar
  62. Floridia, M., Giuliano, M., Palmisano, L., & Vella, S. (2008). Gender differences in the treatment of HIV infection. Pharmacological Research, 58(3), 173–182.PubMedCrossRefGoogle Scholar
  63. Gandhi, M., Bacchetti, P., Miotti, P., Quinn, T. C., Veronese, F., & Greenblatt, R. M. (2002). Does patient sex affect human immunodeficiency virus levels? Clinical Infectious Diseases, 35(3), 313–322.PubMedCrossRefGoogle Scholar
  64. Gardner, E. M., McLees, M. P., Steiner, J. F., Del Rio, C., & Burman, W. J. (2011). The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clinical Infectious Diseases, 52(6), 793–800.PubMedPubMedCentralCrossRefGoogle Scholar
  65. Gay, C., Portillo, C. J., Kelly, R., Coggins, T., Davis, H., Aouizerat, B. E., … Lee, K. A. (2011). Self-reported medication adherence and symptom experience in adults with HIV. Journal of the Association of Nurses in AIDS Care, 22(4), 257–268.PubMedCrossRefGoogle Scholar
  66. Geronimus, A. T., Hicken, M., Keene, D., & Bound, J. (2006). “Weathering” and age patterns of allostatic load scores among blacks and whites in the United States. American Journal of Public Health, 96(5), 826–833.PubMedPubMedCentralCrossRefGoogle Scholar
  67. Goffman, E. (2009). Stigma: Notes on the management of spoiled identity. New York, NY: Simon and Schuster.Google Scholar
  68. Granich, R. M., Gilks, C. F., Dye, C., De Cock, K. M., & Williams, B. G. (2009). Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: A mathematical model. The Lancet, 373(9657), 48–57.CrossRefGoogle Scholar
  69. Grant, R. M., Anderson, P. L., McMahan, V., Liu, A., Amico, K. R., Mehrotra, M., … Buchbinder, S. (2014). Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: A cohort study. The Lancet Infectious Diseases, 14(9), 820–829.PubMedPubMedCentralCrossRefGoogle Scholar
  70. Grindley, L. (2014, September 15). Is undetectable the new safe sex? Retrieved from https://www.hivplusmag.com/sex-dating/2014/09/15/undetectable-new-safe-sex
  71. Grulich, A. E., van Leeuwen, M. T., Falster, M. O., & Vajdic, C. M. (2007). Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: A meta-analysis. The Lancet, 370(9581), 59–67.CrossRefGoogle Scholar
  72. Günthard, H. F., Saag, M. S., Benson, C. A., Del Rio, C., Eron, J. J., Gallant, J. E., & Gandhi, R. T. (2016). Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the International Antiviral Society—USA panel. JAMA, 316(2), 191–210.PubMedPubMedCentralCrossRefGoogle Scholar
  73. Hall, H. I., McDavid, K., Ling, Q., & Sloggett, A. (2006). Determinants of progression to AIDS or death after HIV diagnosis, United States, 1996 to 2001. Annals of Epidemiology, 16(11), 824–833.PubMedCrossRefGoogle Scholar
  74. Health Resources & Services Administration. (2013). A guide to the clinical care of women with HIV, 2013 edition. Retrieved from https://hab.hrsa.gov/sites/default/files/hab/clinical-quality-management/womenwithAIDS.pdf
  75. Health Resources & Services Administration. (2014). Guide for HIV/AIDS clinical care, 2014. Retrieved from https://hab.hrsa.gov/sites/default/files/hab/clinical-quality-management/2014guide.pdf
  76. Health Resources & Services Administration. (2016, November). Part D: A living history. Retrieved from https://hab.hrsa.gov/livinghistory/programs/Part-D.htm
  77. Henry J. Kaiser Family Foundation. (2016, October). Medicaid and HIV fact sheet. Retrieved from http://files.kff.org/attachment/Fact-Sheet-Medicaid-and-HIV
  78. Henry J. Kaiser Family Foundation. (2017, February 1). The Ryan White HIV/AIDS program: The basics. Retrieved from http://www.kff.org/hivaids/fact-sheet/the-ryan-white-hivaids-program-the-basics/
  79. Hill-Collins, P. (2002). Black feminist thought: Knowledge, consciousness, and the politics of empowerment. New York, NY: Routledge.CrossRefGoogle Scholar
  80. Hoppe, T. (2017). Punishing disease: HIV and the criminalization of sickness. Oakland, CA: University of California Press.Google Scholar
  81. Hull, M. W., Wu, Z., & Montaner, J. S. (2012). Optimizing the engagement of care cascade: A critical step to maximize the impact of HIV treatment as prevention. Current Opinion in HIV and AIDS, 7(6), 579–586.PubMedCrossRefGoogle Scholar
  82. Hunt, P. W. (2012). HIV and inflammation: Mechanisms and consequences. Current HIV/AIDS Reports, 9(2), 139–147.PubMedCrossRefGoogle Scholar
  83. Insight Start Study Group. (2015). Initiation of antiretroviral therapy in early asymptomatic HIV infection. The New England Journal of Medicine, 373, 795–807.CrossRefGoogle Scholar
  84. Kaiser Family Foundation. (2017). Women’s health insurance coverage [fact sheet]. Retrieved from https://www.kff.org/womens-health-policy/fact-sheet/womens-health-insurance-coverage-fact-sheet/
  85. Kalichman, S. C., Cherry, C., Amaral, C., White, D., Kalichman, M. O., Pope, H., … Macy, R. (2010). Health and treatment implications of food insufficiency among people living with HIV/AIDS, Atlanta, Georgia. Journal of Urban Health, 87(4), 631–641.PubMedPubMedCentralCrossRefGoogle Scholar
  86. Kalichman, S. C., Grebler, T., Amaral, C. M., McNerey, M., White, D., Kalichman, M. O., … Eaton, L. (2013). Intentional non-adherence to medications among HIV positive alcohol drinkers: Prospective study of interactive toxicity beliefs. Journal of General Internal Medicine, 28(3), 399–405.PubMedCrossRefGoogle Scholar
  87. Kalichman, S. C., Williams, E. A., Cherry, C., Belcher, L., & Nachimson, D. (1998). Sexual coercion, domestic violence, and negotiating condom use among low-income African American women. Journal of Women's Health, 7(3), 371–378.PubMedCrossRefGoogle Scholar
  88. Kates, J., & Dawson, L. (2017, February 14). Insurance coverage changes for people with HIV under the ACA. Henry J. Kaiser Family Foundation. Retrieved from http://files.kff.org/attachment/Data-Note-Insurance-Coverage-Changes-for-People-with-HIV-Under-the-ACA
  89. Kelly, B., Raphael, B., Judd, F., Perdices, M., Kernutt, G., Burnett, P., … Burrows, G. (1998). Posttraumatic stress disorder in response to HIV infection. General Hospital Psychiatry, 20(6), 345–352.PubMedCrossRefGoogle Scholar
  90. Kempf, M. C., McLeod, J., Boehme, A. K., Walcott, M. W., Wright, L., Seal, P., … Moneyham, L. (2010). A qualitative study of the barriers and facilitators to retention-in-care among HIV-positive women in the rural southeastern United States: Implications for targeted interventions. AIDS Patient Care and STDs, 24(8), 515–520.PubMedCrossRefGoogle Scholar
  91. Kempf, M. C., Pisu, M., Dumcheva, A., Westfall, A. O., Kilby, J. M., & Saag, M. S. (2009). Gender differences in discontinuation of antiretroviral treatment regimens. Journal of Acquired Immune Deficiency Syndromes (1999), 52(3), 336–341.CrossRefGoogle Scholar
  92. Kilpatrick, D. G., Resnick, H. S., Milanak, M. E., Miller, M. W., Keyes, K. M., & Friedman, M. J. (2013). National estimates of exposure to traumatic events and PTSD prevalence using DSM-IV and DSM-5 criteria. Journal of Traumatic Stress, 26(5), 537–547.PubMedPubMedCentralCrossRefGoogle Scholar
  93. King, M. S. (2016). Five reasons ‘HIV undetectable’ must equal ‘untransmittable’. Retrieved from http://marksking.com/my-fabulous-disease/five-reasons-hiv-undetectable-must-equal-untransmittable/
  94. Kirby, D. (2002). The impact of schools and school programs upon adolescent sexual behavior. Journal of Sex Research, 39(1), 27–33.PubMedCrossRefGoogle Scholar
  95. Krawczyk, C. S., Funkhouser, E., Kilby, J. M., & Vermund, S. H. (2006). Delayed access to HIV diagnosis and care: Special concerns for the Southern United States. AIDS Care, 18(S1), 35–44.CrossRefGoogle Scholar
  96. Krieger, N. (2001). Theories for social epidemiology in the 21st century: An ecosocial perspective. International Journal of Epidemiology, 30(4), 668–677.PubMedCrossRefGoogle Scholar
  97. Lampe, M. A., Smith, D. K., Anderson, G. J., Edwards, A. E., & Nesheim, S. R. (2011). Achieving safe conception in HIV-discordant couples: The potential role of oral preexposure prophylaxis (PrEP) in the United States. American Journal of Obstetrics and Gynecology, 204(6), 488.e1–8.PubMedCrossRefGoogle Scholar
  98. Lehman, J. S., Carr, M. H., Nichol, A. J., Ruisanchez, A., Knight, D. W., Langford, A. E., … Mermin, J. H. (2014). Prevalence and public health implications of state laws that criminalize potential HIV exposure in the United States. AIDS and Behavior, 18(6), 997–1006.PubMedPubMedCentralCrossRefGoogle Scholar
  99. Leserman, J. (2008). Role of depression, stress, and trauma in HIV disease progression. Psychosomatic Medicine, 70(5), 539–545.PubMedCrossRefGoogle Scholar
  100. Lillie-Blanton, M., Stone, V. E., Snow Jones, A., Levi, J., Golub, E. T., Cohen, M. H., … Wilson, T. E. (2010). Association of race, substance abuse, and health insurance coverage with use of highly active antiretroviral therapy among HIV-infected women, 2005. American Journal of Public Health, 100(8), 1493–1499.PubMedPubMedCentralCrossRefGoogle Scholar
  101. Lopez, E. J., Jones, D. L., Villar-Loubet, O. M., Arheart, K. L., & Weiss, S. M. (2010). Violence, coping, and consistent medication adherence in HIV-positive couples. AIDS Education and Prevention, 22(1), 61–68.PubMedPubMedCentralCrossRefGoogle Scholar
  102. Loutfy, M. R., Sherr, L., Sonnenberg-Schwan, U., Walmsley, S. L., Johnson, M., & Monforte, A. D. A. (2013). Caring for women living with HIV: Gaps in the evidence. Journal of the International AIDS Society, 16(1), 1–14. https://doi.org/10.7448/IAS.16.1.18509 CrossRefGoogle Scholar
  103. Maas, A. (2013, June). Anthem settles suit over mandatory mail order for HIV/AIDS drugs. AIS Health. Retrieved from https://aishealth.com/archive/nspn0613-06
  104. Machtinger, E. L., Wilson, T. C., Haberer, J. E., & Weiss, D. S. (2012). Psychological trauma and PTSD in HIV-positive women: A meta-analysis. AIDS and Behavior, 16(8), 2091–2100.PubMedCrossRefGoogle Scholar
  105. Magnus, M., Herwehe, J., Murtaza-Rossini, M., Reine, P., Cuffie, D., Gruber, D., & Kaiser, M. (2013). Linking and retaining HIV patients in care: The importance of provider attitudes and behaviors. AIDS Patient Care and STDs, 27(5), 297–303.PubMedPubMedCentralCrossRefGoogle Scholar
  106. Mahajan, A. P., Sayles, J. N., Patel, V. A., Remien, R. H., Ortiz, D., Szekeres, G., & Coates, T. J. (2008). Stigma in the HIV/AIDS epidemic: A review of the literature and recommendations for the way forward. AIDS, 22(Suppl 2), S67–S79.PubMedPubMedCentralCrossRefGoogle Scholar
  107. Malta, M., Strathdee, S. A., Magnanini, M. M., & Bastos, F. I. (2008). Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: A systematic review. Addiction, 103(8), 1242–1257.PubMedCrossRefGoogle Scholar
  108. Marks, G., Gardner, L. I., Craw, J., & Crepaz, N. (2010). Entry and retention in medical care among HIV-diagnosed persons: A meta-analysis. AIDS, 24(17), 2665–2678.PubMedCrossRefGoogle Scholar
  109. Marmot, M. (2005). Social determinants of health inequalities. The Lancet, 365(9464), 1099–1104.CrossRefGoogle Scholar
  110. Martin, L., & Kagee, A. (2011). Lifetime and HIV-related PTSD among persons recently diagnosed with HIV. AIDS and Behavior, 15(1), 125–131.PubMedCrossRefGoogle Scholar
  111. McAfee, D. (2015, March 30). United, HIV/AIDS patients settle mail-order drug dispute law 360. Ret1rieved from https://www.law360.com/articles/520419/united-hiv-AIDS-patients-settle-mail-order-drug-dispute
  112. McEwen, B. S. (1998). Stress, adaptation, and disease: Allostasis and allostatic load. Annals of the New York Academy of Sciences, 840(1), 33–44.PubMedCrossRefGoogle Scholar
  113. McFall, A. M., Dowdy, D. W., Zelaya, C. E., Murphy, K., Wilson, T. E., Young, M. A., … Althoff, K. N. (2013). Understanding the disparity: Predictors of virologic failure in women using highly active antiretroviral therapy vary by race and/or ethnicity. Journal of Acquired Immune Deficiency Syndromes (1999), 64(3), 289–298.CrossRefGoogle Scholar
  114. McManus, K. A., Engelhard, C. L., & Dillingham, R. (2013). Current challenges to the United States’ AIDS drug assistance program and possible implications of the Affordable Care Act. AIDS Research and Treatment, 2013, 1–7. https://doi.org/10.1155/2013/350169 CrossRefGoogle Scholar
  115. Merenstein, D., Schneider, M. F., Cox, C., Schwartz, R., Weber, K., Robison, E., … Plankey, M. W. (2009). Association of child care burden and household composition with adherence to highly active antiretroviral therapy in the women’s interagency HIV study. AIDS Patient Care and STDs, 23(4), 289–296.PubMedPubMedCentralCrossRefGoogle Scholar
  116. Messer, L. C., Quinlivan, E. B., Parnell, H., Roytburd, K., Adimora, A. A., Bowditch, N., & DeSousa, N. (2013). Barriers and facilitators to testing, treatment entry, and engagement in care by HIV-positive women of color. AIDS Patient Care and STDs, 27(7), 398–407.PubMedPubMedCentralCrossRefGoogle Scholar
  117. Meyer, H. (2016). Clinton’s Medicare buy-in concept revives debate on public option. Modern Healthcare, 46(20), 10–11.PubMedGoogle Scholar
  118. Mojola, S. A. (2014). Love, money, and HIV: Becoming a modern African woman in the age of AIDS. Oakland, CA: University of California Press.CrossRefGoogle Scholar
  119. Montaner, J. S., Lima, V. D., Harrigan, P. R., Lourenço, L., Yip, B., Nosyk, B., … Hogg, R. S. (2014). Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: The “HIV Treatment as Prevention” experience in a Canadian setting. PLoS One, 9(2), 1–10. https://doi.org/10.1371/journal.pone.0087872 CrossRefGoogle Scholar
  120. Montessori, V., Press, N., Harris, M., Akagi, L., & Montaner, J. S. (2004). Adverse effects of antiretroviral therapy for HIV infection. Canadian Medical Association Journal, 170(2), 229–238.PubMedGoogle Scholar
  121. Moreno, C. L. (2007). The relationship between culture, gender, structural factors, trauma, and HIV/AIDS for Latinas. Qualitative Health Research, 17(3), 340–352.PubMedCrossRefGoogle Scholar
  122. Mugavero, M. J., Lin, H. Y., Willig, J. H., Westfall, A. O., Ulett, K. B., Routman, J. S., … Allison, J. J. (2009). Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clinical Infectious Diseases, 48(2), 248–256.PubMedPubMedCentralCrossRefGoogle Scholar
  123. National Association of State AIDS Directors. (2017). National ADAP monitoring: 2017 annual report. Retrieved from https://www.nastad.org/sites/default/files/nas001_report_v4_spreads-new3.pdf
  124. Nguyen, V. K., Bajos, N., Dubois-Arber, F., O’Malley, J., & Pirkle, C. M. (2011). Remedicalizing an epidemic: From HIV treatment as prevention to HIV treatment is prevention. AIDS, 25(3), 291–293.PubMedCrossRefGoogle Scholar
  125. O’Cleirigh, C., Valentine, S. E., Pinkston, M., Herman, D., Bedoya, C. A., Gordon, J. R., & Safren, S. A. (2015). The unique challenges facing HIV-positive patients who smoke cigarettes: HIV viremia, ART adherence, engagement in HIV care, and concurrent substance use. AIDS and Behavior, 19(1), 178–185.PubMedPubMedCentralCrossRefGoogle Scholar
  126. Operario, D., & Nemoto, T. (2010). HIV in transgender communities: Syndemic dynamics and a need for multicomponent interventions. Journal of Acquired Immune Deficiency Syndromes (1999), 55(Suppl 2), S91–S93.CrossRefGoogle Scholar
  127. Parker, R., & Aggleton, P. (2003). HIV and AIDS-related stigma and discrimination: A conceptual framework and implications for action. Social Science & Medicine, 57(1), 13–24.CrossRefGoogle Scholar
  128. Poizot-Martin, I., Solas, C., Allemand, J., Obry-Roguet, V., Pradel, V., Bregigeon, S., … Lacarelle, B. (2013). Renal impairment in patients receiving a tenofovir-cART regimen: Impact of tenofovir trough concentration. Journal of Acquired Immune Deficiency Syndromes, 62(4), 375–380.PubMedCrossRefGoogle Scholar
  129. Pomerantz, R. J., de la Monte, S. M., Donegan, S. P., Rota, T. R., Vogt, M. W., Craven, D. E., & Hirsch, M. S. (1988). Human immunodeficiency virus (HIV) infection of the uterine cervix. Annals of Internal Medicine, 108(3), 321–327.PubMedCrossRefGoogle Scholar
  130. Poteat, T., Wirtz, A. L., Radix, A., Borquez, A., Silva-Santisteban, A., Deutsch, M. B., … Operario, D. (2015). HIV risk and preventive interventions in transgender women sex workers. The Lancet, 385(9964), 274–286.CrossRefGoogle Scholar
  131. Poz. (2017, May 31). HIV drug assistance programs. Retrieved from https://www.poz.com/basics/hiv-basics/drug-assistance-programs
  132. Prevention Access Campaign. (2017, July 6). Consensus statement. Retrieved from https://www.preventionaccess.org/consensus
  133. Pulerwitz, J., Amaro, H., Jong, W. D., Gortmaker, S. L., & Rudd, R. (2002). Relationship power, condom use and HIV risk among women in the USA. AIDS Care, 14(6), 789–800.PubMedCrossRefGoogle Scholar
  134. Puskas, C. M., Forrest, J. I., Parashar, S., Salters, K. A., Cescon, A. M., Kaida, A., … Hogg, R. S. (2011). Women and vulnerability to HAART non-adherence: A literature review of treatment adherence by gender from 2000 to 2011. Current HIV/AIDS Reports, 8(4), 277.PubMedCrossRefGoogle Scholar
  135. Raymond, A., Hill, A., & Pozniak, A. (2013). Large disparities in HIV treatment cascades between eight European and high-income countries-analysis of break points. Journal of the International AIDS Society, 17(4 Suppl 3), 1–2. https://doi.org/10.7448/IAS.17.4.19507 CrossRefGoogle Scholar
  136. Raz, L., & Miller, V. M. (2013). Considerations of sex and gender differences in preclinical and clinical trials. In V. Regitz-Zagrosek (Ed.), Sex and gender differences in pharmacology (pp. 127–147). New York, NY: Springer.CrossRefGoogle Scholar
  137. Reif, S., Safley, D., McAllaster, C., Wilson, E., & Whetten, K. (2017). State of HIV in the US deep South. Journal of Community Health, 47(1), 1–10.Google Scholar
  138. Reif, S., Whetten, K., Lowe, K., & Ostermann, J. (2006). Association of unmet needs for support services with medication use and adherence among HIV-infected individuals in the southeastern United States. AIDS Care, 18(4), 277–283.PubMedCrossRefGoogle Scholar
  139. Reisner, S. L., Poteat, T., Keatley, J., Cabral, M., Mothopeng, T., Dunham, E., … Baral, S. D. (2016). Global health burden and needs of transgender populations: A review. The Lancet, 388(10042), 412–436.CrossRefGoogle Scholar
  140. Reskin, B. F., & Roos, P. A. (2009). Job queues, gender queues: Explaining women's inroads into male occupations. Philadelphia, PA: Temple University Press.Google Scholar
  141. Ridgeway, C. L. (2011). Framed by gender: How gender inequality persists in the modern world. New York, NY: Oxford University Press.CrossRefGoogle Scholar
  142. Riley, E. D., Gandhi, M., Hare, C. B., Cohen, J., & Hwang, S. W. (2007). Poverty, unstable housing, and HIV infection among women living in the United States. Current HIV/AIDS Reports, 4(4), 181–186.PubMedCrossRefGoogle Scholar
  143. Rocheleau, G., Brumme, C. J., Shoveller, J., Lima, V. D., & Harrigan, P. R. (2018). Longitudinal trends of HIV drug resistance in a large Canadian cohort, 1996–2016. Clinical Microbiology and Infection, 24(2), 185–191.​PubMedCrossRefGoogle Scholar
  144. Rodger, A. J., Cambiano, V., Bruun, T., Vernazza, P., Collins, S., Van Lunzen, J., … Asboe, D. (2016). Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA, 316(2), 171–181.PubMedCrossRefGoogle Scholar
  145. Rodriguez, C. (n.d.). Living with HIV: The choices and consequences of disclosure. The Center for HIV Law and Policy. Retrieved from https://www.hivlawandpolicy.org/fine-print-blog/living-hiv-choices-and-consequences-disclosure
  146. Royce, R. A., Seña, A., Cates, W., Jr., & Cohen, M. S. (1997). Sexual transmission of HIV. New England Journal of Medicine, 336(15), 1072–1078.PubMedCrossRefGoogle Scholar
  147. Samji, H., Cescon, A., Hogg, R. S., Modur, S. P., Althoff, K. N., Buchacz, K., … Justice, A. (2013). Closing the gap: Increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One, 8(12), 1–8. https://doi.org/10.1371/journal.pone.0081355 CrossRefGoogle Scholar
  148. Sandelowski, M., Lambe, C., & Barroso, J. (2004). Stigma in HIV-positive women. Journal of Nursing Scholarship, 36(2), 122–128.PubMedCrossRefGoogle Scholar
  149. Schackman, B. R., Gebo, K. A., Walensky, R. P., Losina, E., Muccio, T., Sax, P. E., … Freedbeerg, K. A. (2006). The lifetime cost of current human immunodeficiency virus care in the United States. Medical Care, 44(11), 990–997.PubMedCrossRefGoogle Scholar
  150. Scherzer, R., Estrella, M., Yongmei, L. I., Deeks, S. G., Grunfeld, C., & Shlipak, M. G. (2012). Association of tenofovir exposure with kidney disease risk in HIV infection. AIDS, 26(7), 867–875.PubMedPubMedCentralCrossRefGoogle Scholar
  151. Schoen, C., Buttorff, C., Andersen, M., & Davis, K. (2015). Policy options to expand Medicare’s low-income provisions to improve access and affordability. Health Affairs, 34(12), 2086–2094.PubMedCrossRefGoogle Scholar
  152. Schwartz, R. M., Weber, K. M., Schechter, G. E., Connors, N. C., Gousse, Y., Young, M. A., & Cohen, M. H. (2014). Psychosocial correlates of gender-based violence among HIV-infected and HIV-uninfected women in three US cities. AIDS Patient Care and STDs, 28(5), 260–267.PubMedPubMedCentralCrossRefGoogle Scholar
  153. Siddiqi, A. E., Hall, H. I., Hu, X., & Song, R. (2016). Population-based estimates of life expectancy after HIV diagnosis: United States 2008–2011. Journal of Acquired Immune Deficiency Syndromes, 72(2), 230–236.PubMedCrossRefGoogle Scholar
  154. Snider, J. T., Juday, T., Romley, J. A., Seekins, D., Rosenblatt, L., Sanchez, Y., & Goldman, D. P. (2014). Nearly 60,000 uninsured and low-income people with HIV/AIDS live in states that are not expanding Medicaid. Health Affairs, 33(3), 386–393.PubMedCrossRefGoogle Scholar
  155. Swan, H., & O’Connell, D. J. (2012). The impact of intimate partner violence on women’s condom negotiation efficacy. Journal of Interpersonal Violence, 27(4), 775–792.PubMedCrossRefGoogle Scholar
  156. Taylor, A. W., Nesheim, S. R., Zhang, X., Song, R., FitzHarris, L. F., Lampe, M. A., … Sweeney, P. (2017). Estimated perinatal HIV infection among infants born in the United States, 2002–2013. JAMA Pediatrics, 171(5), 435–442.PubMedPubMedCentralCrossRefGoogle Scholar
  157. Thomas, K., & Pollack, A. (2015, July 15). Specialty pharmacies proliferate, along with questions. New York Times. Retrieved from https://www.nytimes.com/2015/07/16/business/specialty-pharmacies-proliferate-along-with-questions.html
  158. Townsend, C. L., Byrne, L., Cortina-Borja, M., Thorne, C., de Ruiter, A., Lyall, H., … Tookey, P. A. (2014). Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000–2011. AIDS, 28(7), 1049–1057.PubMedCrossRefGoogle Scholar
  159. UNAIDS. (2016). 2015 Progress report on the global plan towards the elimination of new HIV infections among children and keeping their mothers alive. Retrieved from http://www.unAIDS.org/sites/default/files/media_asset/JC2774_2015ProgressReport_GlobalPlan_en.pdf
  160. Valdiserri, R. O. (2002). HIV/AIDS stigma: An impediment to public health. American Journal of Public Health, 92(3), 341–342.PubMedPubMedCentralCrossRefGoogle Scholar
  161. Vanable, P. A., Carey, M. P., Blair, D. C., & Littlewood, R. A. (2006). Impact of HIV-related stigma on health behaviors and psychological adjustment among HIV-positive men and women. AIDS and Behavior, 10(5), 473–482.PubMedPubMedCentralCrossRefGoogle Scholar
  162. Vyavaharkar, M., Moneyham, L., Corwin, S., Saunders, R., Annang, L., & Tavakoli, A. (2010). Relationships between stigma, social support, and depression in HIV-infected African American women living in the rural Southeastern United States. Journal of the Association of Nurses in AIDS Care, 21(2), 144–152.PubMedCrossRefGoogle Scholar
  163. Walensky, R. P., Freedberg, K. A., Weinstein, M. C., & Paltiel, A. D. (2007). Cost-effectiveness of HIV testing and treatment in the United States. Clinical Infectious Diseases, 45(Suppl 4), S248–S254.PubMedPubMedCentralCrossRefGoogle Scholar
  164. Watkins-Hayes, C. (2014). Intersectionality and the sociology of HIV/AIDS: Past, present, and future research directions. Annual Review of Sociology, 40, 431–457.CrossRefGoogle Scholar
  165. Weiser, S. D., Young, S. L., Cohen, C. R., Kushel, M. B., Tsai, A. C., Tien, P. C., … Bangsberg, D. R. (2011). Conceptual framework for understanding the bidirectional links between food insecurity and HIV/AIDS. The American Journal of Clinical Nutrition, 94(6), 1729S–1739S.PubMedPubMedCentralCrossRefGoogle Scholar
  166. Whetten, K., Reif, S., Whetten, R., & Murphy-McMillan, L. K. (2008). Trauma, mental health, distrust, and stigma among HIV-positive persons: Implications for effective care. Psychosomatic Medicine, 70(5), 531–538.PubMedCrossRefGoogle Scholar
  167. White House Office of National AIDS Policy. (2015, July). National HIV/AIDS strategy for the United States: Updated to 2020. Retrieved from https://www.hiv.gov/sites/default/files/nhas-update.pdf
  168. Whiteside, A. (2016). HIV & AIDS: A very short introduction. Oxford, England: Oxford University Press.CrossRefGoogle Scholar
  169. Wilper, A. P., Woolhandler, S., Lasser, K. E., McCormick, D., Bor, D. H., & Himmelstein, D. U. (2009). Health insurance and mortality in US adults. American Journal of Public Health, 99(12), 2289–2295.PubMedPubMedCentralCrossRefGoogle Scholar
  170. World Health Organization. (2013, June). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Retrieved from http://www.who.int/hiv/pub/guidelines/arv2013/intro/keyterms/en/
  171. Wyatt, G. E., Myers, H. F., Williams, J. K., Kitchen, C. R., Loeb, T., Carmona, J. V., … Presley, N. (2002). Does a history of trauma contribute to HIV risk for women of color? Implications for prevention and policy. American Journal of Public Health, 92(4), 660–665.PubMedPubMedCentralCrossRefGoogle Scholar
  172. Yin, M. T., Zhang, C. A., McMahon, D. J., Ferris, D. C., Irani, D., Colon, I., … Shane, E. (2011). Higher rates of bone loss in postmenopausal HIV-infected women: A longitudinal study. The Journal of Clinical Endocrinology & Metabolism, 97(2), 554–562.CrossRefGoogle Scholar
  173. Zierler, S., Feingold, L., Laufer, D., Velentgas, P., Kantrowitz-Gordon, I., & Mayer, K. (1991). Adult survivors of childhood sexual abuse and subsequent risk of HIV infection. American Journal of Public Health, 81(5), 572–575.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Authors and Affiliations

  1. 1.Providence CollegeProvidenceUSA
  2. 2.RAND CorporationSanta MonicaUSA

Personalised recommendations